Alzheimer's Disease Market Research Reports & Industry Analysis
A gradual loss of neurons later in adulthood does not result in significant alteration in brain function during the usual life span. However, the older one gets, the greater the neurologic impairment. Excessive neuronal degeneration in adulthood is called Alzheimer’s disease or senile dementia and is distinguished from the normal changes in aging. Alzheimer’s disease is a progressive disease which results in death of the brain cells causing memory lapses, behavioral issues, and disruption of thinking processes. The disease is considered fatal. Age and generic inheritance are the two key risk factors for developing Alzheimer’s disease. These are also risk factors that are not preventable. However, other preventable risk factors have been linked to the development of AD, including environment, diet, and overall general health. A combination of risk factors is often responsible for the disease.
Alzheimer’s disease is estimated to affect up to 6% of the population over 65. Life expectancy has been increasing around the world due to advances in healthcare, medical research, sanitation, and nutrition. This provides a setting for a higher number of Alzheimer’s disease patients in the future as the population continues to add years to their life.
Alzheimer's Disease Industry Research & Market Reports
-
The 2023-2028 World Outlook for Alzheimer's Disease Therapeutics and Diagnostics
... the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow ... Read More
-
The 2023-2028 World Outlook for Dementia Associated with Alzheimer's Diseases
... the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow ... Read More
-
The 2023-2028 World Outlook for Alzheimer's Disease Treatments
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2023-2028 World Outlook for Neurological Biomarkers for Alzheimers and Parkinsons Diseases
... estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. ... Read More
-
Alzheimer’s Drugs Market Size and Share - Global Forecast, 2022 - 2028
... encounters various behavioral change with dementia, as a primary symptoms, which gets worse as disease progress. It majorly affects people of age group 65 and above. Currently, there is no therapeutic cure available for Alzheimer’s ... Read More
-
The 2023-2028 World Outlook for Alzheimer's Diseases
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
Alzheimer’s Therapeutics Market
... a comprehensive assessment of the most important market dynamics. On conducting thorough research on the historical as well as current growth parameters of the Alzheimer’s therapeutics market, the growth prospects of the market are obtained ... Read More
-
Alzheimer's Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update, provides an overview of the Alzheimer's Disease (Central Nervous System) pipeline landscape. Alzheimer's disease is a progressive, degenerative condition causing damage to the memory ... Read More
-
Wearable Brain Devices Market Size, Share & Trends Analysis Report By Channel Type (32-Channel Type, 12-Channel Type), By Application (Medical Setting, AR/VR Gaming Settings), By End User, By Region, And Segment Forecasts, 2022 - 2030
... Wearable Brain Devices Market Growth & Trends The global wearable brain devices market size is anticipated to reach USD 668.5 million by 2030, registering a CAGR of 12.33%, according to a new report by Grand ... Read More
-
Global Psychedelic Drugs Market: Analysis By Indication (ADHD, MDD, Bipolar, Migraine, Anxiety, Parkinson’s Disease, OUD, Alzheimer’s Disease, AUD, TUD, Eating Disorder, and Narcolepsy) Size & Trends with Impact of Covid-19 and Forecast up to 2025
... Scope of the Report The report provides an in depth analysis of the global psychedelic drugs market by value, by indication, etc. The report also provides a detailed analysis of the COVID-19 impact on the ... Read More
-
Optogenetics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
... a CAGR of 3.86% during 2022-2027. The ongoing COVID-19 pandemic globally is expected to have a significant impact on the optogenetics market. According to the article published by PUS University in February 2022, by Shanet ... Read More
-
Global Lewy Body Dementia Treatment Market Size study, by Drug Type (Cholinesterase Inhibitors, Antipsychotic Drugs, Antidepressants, Benzodiazepine, Modafinil) by Application Type (Parkinson’s Disease, Alzheimer’s Disease) by Mode of Purchase (Prescription and Over the Counter) by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Others) and Regional Forecasts 2022-2028
... Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Others) and Regional Forecasts 2022-2028 Global Lewy Body Dementia Treatment Market is valued approximately USD XX billion in 2021 and is anticipated to grow with a ... Read More
-
Global Johnson Neuroectodermal Syndrome Market Size study, by Drug Class (Immunomodulators, Interferons, Decarboxylase Inhibitors, Dopamine Agonists and Others) by Disease Indication (Multiple Sclerosis, Parkinson’s Disease, Alzheimer's Disease, Spinal Muscular Atrophy (SMA) and Others), by Route of Administration (Oral, Injection, Transdermal), by Distribution Channel (Hospital Pharmacy, Retail Pharmacy and Online Pharmacy) and Regional Forecasts 2022-2028
... of Administration (Oral, Injection, Transdermal), by Distribution Channel (Hospital Pharmacy, Retail Pharmacy and Online Pharmacy) and Regional Forecasts 2022-2028 Global Johnson Neuroectodermal Syndrome Market is valued approximately USD XX billion in 2022 and is anticipated ... Read More
-
Brain Disease Modalities and Software Market - A Global and Regional Analysis: Focus on Product, Indication, Patient Type, End User, and Regional Analysis - Analysis and Forecast, 2022-2031
... and Software Market Segmentation Indication - Brain Diseases (Brain and Central Nervous System Cancer, Idiopathic Epilepsy, Ischemic stroke, and Other Brain Diseases) and Neurodegenerative Diseases (Alzheimer’s Disease, Multiple Sclerosis, Parkinson’s Disease, Motor Neuron Disease, and ... Read More
-
Global Alzheimer Drugs Market (2022 Edition) – Analysis By Drug Class (Cholinergic, Memantine, Combined Drugs, Others), Distribution Channel, By Region, By Country: Market Insights, Pipeline and Forecast with Impact of Covid-19 (2022-2027)
... to Azoth Analytics research report, the Global Alzheimer's Drugs Market was valued at USD 6537.0 Million in the year 2021. Diabetes, obesity, heart diseases and high blood pressure (BP), in confluence with sedentary lifestyles, unhealthy ... Read More
-
5G in Healthcare Market Size, Share & Trends Analysis By Component, By Application, By End User, Regional Outlook, Competitive Strategies and Segment Forecasts to 2030
... 3.9 Bn by 2030 According to SPER Market Research, the 5G in healthcare market estimated to reach USD 3.9 Bn by 2030 with a CAGR of 69.8%. Technologies such as Telehealth and robotics services are ... Read More
-
Neurodegenerative Disease Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
... 44.90 billion in 2026, with a CAGR of 2.30% over the forecast period. The COVID-19 impact on the Neurodegenerative Disease market is expected to be significant as the pandemic has impacted the workflows of clinical ... Read More
-
Alzheimer's Disease - Market Insight, Epidemiology and Market Forecast -2032
... States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Alzheimer's Disease market report provides current treatment practices, emerging drugs, Alzheimer's Disease market share of the individual therapies, current and forecasted Alzheimer's Disease ... Read More
-
Alzheimer's disease (AD) - Epidemiology Forecast to 2032
... Spain, Italy, France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Alzheimer's disease (AD) Understanding The ... Read More
-
Global Alzheimer's Disease Market and Competitive Landscape – 2017
... sales, market forecast, product forecasts, and market shares. This study accurately estimates and forecast Alzheimer's Disease market size and drug sales. This research also provides insights into Alzheimer's Disease epidemiology and late stage pipeline. The ... Read More
-
Potential "Pipeline Disruptors" - New Products That Will Drive The Future Pharmaceutical Market
... six areas are expected to show the strongest pipeline impact and candidates are likely to replace current therapies. The market is evaluated for 2015 and 2016 with forecast data provided through 2022. Forecast data were ... Read More
Research Assistance
